Screener
Chimera Investment Corp. CIM Gain (Loss) on Sale of Derivatives
Gain (Loss) on Sale of Derivatives at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Chimera Investment Corp. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfDerivatives.
The source filing: Chimera Investment Corp.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001409493-26-000050
| Line item | For the Quarters Ended / June 30, 2026 | For the Quarters Ended / June 30, 2025 | For the Six Months Ended / June 30, 2026 | For the Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Increase in provision for credit losses | 7,192 | 4,409 | 10,016 | 7,796 |
| Other income (losses): | ||||
| Net unrealized gains (losses) on derivatives | 15,398 | (2,554) | 33,548 | (9,024) |
| Realized gains (losses) on derivatives | 9,527 | (17,954) | 12,397 | (17,872) |
| Periodic interest on derivatives, net | 2,061 | 5,067 | 3,895 | 9,202 |
| Net gains (losses) on derivatives | 26,986 | (15,441) | 49,840 | (17,694) |
| Investment management and advisory fees | 6,540 | 8,810 | 13,704 | 17,745 |
| Interest income from investment in MSR financing receivables, net (3) | 838 | — | 3,149 | — |
Item 1. Consolidated Financial Statements
FAQ
- What is Chimera Investment Corp.'s gain (loss) on sale of derivatives?
- Chimera Investment Corp. (CIM) reported gain (loss) on sale of derivatives of $9.53M in Q2 2026.
- How has Chimera Investment Corp.'s gain (loss) on sale of derivatives changed year-over-year?
- Chimera Investment Corp.'s gain (loss) on sale of derivatives increased by 153.1% year-over-year, from -$17.95M to $9.53M.
- What does gain (loss) on sale of derivatives mean?
- Gain (Loss) on Sale of Derivatives
Ask your AI about Chimera Investment Corp.'s gain (loss) on sale of derivatives.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude